Andres Maldonado
Stock Analyst at HC Wainwright & Co.
(1.79)
# 2,970
Out of 4,847 analysts
95
Total ratings
26.88%
Success rate
-8.12%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Andres Maldonado
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AURA Aura Biosciences | Assumes: Buy | $22 | $6.35 | +246.46% | 1 | May 28, 2025 | |
| ZNTL Zentalis Pharmaceuticals | Reiterates: Buy | $10 | $1.36 | +635.29% | 1 | May 15, 2025 | |
| IBRX ImmunityBio | Reiterates: Buy | $8 | $2.71 | +195.20% | 3 | May 12, 2025 | |
| CRBP Corbus Pharmaceuticals Holdings | Maintains: Buy | $50 → $40 | $8.30 | +381.93% | 2 | May 7, 2025 | |
| TCRX TScan Therapeutics | Maintains: Buy | $15 → $10 | $1.75 | +471.43% | 1 | May 7, 2025 | |
| ERAS Erasca | Reiterates: Buy | $6 | $1.45 | +315.22% | 10 | Apr 30, 2025 | |
| FHTX Foghorn Therapeutics | Reiterates: Buy | $13 | $4.36 | +198.17% | 1 | Apr 30, 2025 | |
| STRO Sutro Biopharma | Reiterates: Neutral | $2 | $0.91 | +118.99% | 1 | Apr 29, 2025 | |
| TARA Protara Therapeutics | Reiterates: Buy | $23 | $3.28 | +601.22% | 1 | Apr 28, 2025 | |
| CGON CG Oncology | Reiterates: Buy | $75 | $26.79 | +179.96% | 13 | Apr 28, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $36 | $6.98 | +415.76% | 14 | Apr 3, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $18 → $6 | $2.63 | +128.14% | 5 | Mar 26, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $15 | $1.36 | +1,002.94% | 16 | Mar 12, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $25 | $4.16 | +500.96% | 2 | Mar 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $50 | $30.94 | +61.60% | 13 | Nov 26, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Buy | $4 | $1.35 | +196.30% | 11 | Nov 11, 2024 |
Aura Biosciences
May 28, 2025
Assumes: Buy
Price Target: $22
Current: $6.35
Upside: +246.46%
Zentalis Pharmaceuticals
May 15, 2025
Reiterates: Buy
Price Target: $10
Current: $1.36
Upside: +635.29%
ImmunityBio
May 12, 2025
Reiterates: Buy
Price Target: $8
Current: $2.71
Upside: +195.20%
Corbus Pharmaceuticals Holdings
May 7, 2025
Maintains: Buy
Price Target: $50 → $40
Current: $8.30
Upside: +381.93%
TScan Therapeutics
May 7, 2025
Maintains: Buy
Price Target: $15 → $10
Current: $1.75
Upside: +471.43%
Erasca
Apr 30, 2025
Reiterates: Buy
Price Target: $6
Current: $1.45
Upside: +315.22%
Foghorn Therapeutics
Apr 30, 2025
Reiterates: Buy
Price Target: $13
Current: $4.36
Upside: +198.17%
Sutro Biopharma
Apr 29, 2025
Reiterates: Neutral
Price Target: $2
Current: $0.91
Upside: +118.99%
Protara Therapeutics
Apr 28, 2025
Reiterates: Buy
Price Target: $23
Current: $3.28
Upside: +601.22%
CG Oncology
Apr 28, 2025
Reiterates: Buy
Price Target: $75
Current: $26.79
Upside: +179.96%
Apr 3, 2025
Reiterates: Buy
Price Target: $36
Current: $6.98
Upside: +415.76%
Mar 26, 2025
Maintains: Buy
Price Target: $18 → $6
Current: $2.63
Upside: +128.14%
Mar 12, 2025
Reiterates: Buy
Price Target: $15
Current: $1.36
Upside: +1,002.94%
Mar 11, 2025
Reiterates: Buy
Price Target: $25
Current: $4.16
Upside: +500.96%
Nov 26, 2024
Maintains: Buy
Price Target: $40 → $50
Current: $30.94
Upside: +61.60%
Nov 11, 2024
Reiterates: Buy
Price Target: $4
Current: $1.35
Upside: +196.30%